• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0

DSC3 Rekombinanter Antikörper

DSC3 Rekombinant Antikörper für Cytometric bead array, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

Cytometric bead array, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

240292A12

Kat-Nr. : 83386-1-PBS

Synonyme

CDHF3, desmocollin 3, Desmocollin 4, DSC, DSC1

Filter:
  • Affinity and Kinetic Characterization of 83386-1-PBS

    Affinity and Kinetic Characterization of 83386-1-PBS

    Biolayer interferometry (BLl) kinetic assay of 83386-1-PBS against Human DSC3 was performed. The affinity constant is below 1 pM.

Geprüfte Anwendungen

Produktinformation

83386-1-PBS bindet in Cytometric bead array, Indirect ELISA DSC3 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen DSC3 fusion protein Ag34648
Vollständiger Name desmocollin 3
Berechnetes Molekulargewicht100 kDa
GenBank-ZugangsnummerNM_001941
Gene symbol DSC3
Gene ID (NCBI) 1825
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Desmocollin-3 (DSC3), also known as CDHF3 and DSC4, is a member of the cadherin superfamily of calcium-dependent cell adhesion molecules and a major component of desmosomes. It has 2 isoforms with molecular masses of 100 and 93 kDa. It is particularly expressed in the vagina, testis, skin, oral mucosa and esophagus. Its subcellular localization is at the cell membrane. Post-translational modifications, including glycosylation, have been described.